
ORGO
Organogenesis Holdings Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
5.035
Open
4.790
VWAP
4.82
Vol
1.35M
Mkt Cap
638.07M
Low
4.6708
Amount
6.52M
EV/EBITDA(TTM)
29.07
Total Shares
132.57M
EV
654.88M
EV/OCF(TTM)
147.66
P/S(TTM)
1.43
Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of regenerative products to address patient needs across the continuum of care. Its wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier, cross-linked with extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types as a protective barrier and extracellular matrix scaffold. Its sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for the management of open wounds in a surgical setting.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
104.75M
-19.57%
--
--
137.95M
+19.77%
--
--
154.90M
+22.3%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Organogenesis Holdings Inc. (ORGO) for FY2025, with the revenue forecasts being adjusted by -0.26% over the past three months. During the same period, the stock price has changed by 7.71%.
Revenue Estimates for FY2025
Revise Downward

-0.26%
In Past 3 Month
Stock Price
Go Up

+7.71%
In Past 3 Month
3 Analyst Rating

19.28% Upside
Wall Street analysts forecast ORGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ORGO is 6.00 USD with a low forecast of 5.00 USD and a high forecast of 7.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
1 Hold
0 Sell
Moderate Buy

19.28% Upside
Current: 5.030

Low
5.00
Averages
6.00
High
7.00

19.28% Upside
Current: 5.030

Low
5.00
Averages
6.00
High
7.00
Morgan Stanley
Drew Ranieri
Hold
Maintains
$4 → $6
2025-03-05
Reason
Morgan Stanley
Drew Ranieri
Price Target
$4 → $6
2025-03-05
Maintains
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Organogenesis Holdings Inc (ORGO.O) is 55.89, compared to its 5-year average forward P/E of 38.31. For a more detailed relative valuation and DCF analysis to assess Organogenesis Holdings Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
38.31
Current PE
55.89
Overvalued PE
124.11
Undervalued PE
-47.49
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
14.47
Current EV/EBITDA
10.79
Overvalued EV/EBITDA
21.38
Undervalued EV/EBITDA
7.56
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
1.69
Current PS
1.22
Overvalued PS
3.01
Undervalued PS
0.36
Financials
Annual
Quarterly
FY2025Q1
YoY :
-21.17%
86.69M
Total Revenue
FY2025Q1
YoY :
+423.86%
-20.18M
Operating Profit
FY2025Q1
YoY :
+797.29%
-18.84M
Net Income after Tax
FY2025Q1
YoY :
+750.00%
-0.17
EPS - Diluted
FY2025Q1
YoY :
+90.25%
-23.56M
Free Cash Flow
FY2025Q1
YoY :
-1.72%
72.64
Gross Profit Margin - %
FY2025Q1
YoY :
-198.08%
-1.53
FCF Margin - %
FY2025Q1
YoY :
+1038.22%
-21.74
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
127.5K
USD
1
6-9
Months
1.4M
USD
7
0-12
Months
0.0
USD
0
Bought
0-3
3
725.3K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
6.5K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
645.0K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
127.5K
USD
1
6-9
Months
1.4M
USD
7
0-12
Months
0.0
USD
0
Bought
0-3
3
725.3K
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
ORGO News & Events
Events Timeline
2025-07-15 (ET)
2025-07-15
09:34:04
Video: Why Organogenesis And MiMedx Are Sinking Today


2025-07-15
09:10:00
Organogenesis 'pleased' with CMS proposal on skin substitute

2025-07-14 (ET)
2025-07-14
16:32:34
Organogenesis, MiMedx fall after CMS rule to cut skin substitutes spending

Sign Up For More Events
Sign Up For More Events
News
4.0
07-15BenzingaCantor Fitzgerald Reiterates Overweight on Organogenesis Holdings, Maintains $7 Price Target
2.0
07-15BenzingaSimulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
2.0
07-15BenzingaWhy Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Sign Up For More News
People Also Watch

USAP
Universal Stainless & Alloy Products Inc
44.990
USD
0.00%

DDD
3D Systems Corp
1.800
USD
-4.26%

METC
Ramaco Resources Inc
22.540
USD
-1.27%

PRTC
PureTech Health PLC
19.069
USD
+0.36%

BSVN
Bank7 Corp
46.960
USD
-0.38%

JILL
JJill Inc
16.490
USD
+0.79%

GRVY
Gravity Co Ltd
62.690
USD
-1.42%

TCMD
Tactile Systems Technology Inc
10.550
USD
+2.93%

CWCO
Consolidated Water Co Ltd
29.660
USD
-0.20%

LSAK
Lesaka Technologies Inc
4.250
USD
-0.47%
FAQ

What is Organogenesis Holdings Inc (ORGO) stock price today?
The current price of ORGO is 5.03 USD — it has increased 5.89 % in the last trading day.

What is Organogenesis Holdings Inc (ORGO)'s business?

What is the price predicton of ORGO Stock?

What is Organogenesis Holdings Inc (ORGO)'s revenue for the last quarter?

What is Organogenesis Holdings Inc (ORGO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Organogenesis Holdings Inc (ORGO)'s fundamentals?

How many employees does Organogenesis Holdings Inc (ORGO). have?
